Cargando…
Personalized Medicine and Molecular Interaction Networks in Amyotrophic Lateral Sclerosis (ALS): Current Knowledge
Multiple genes and mechanisms of pathophysiology have been implicated in amyotrophic lateral sclerosis (ALS), suggesting it is a complex systemic disease. With this in mind, applying personalized medicine (PM) approaches to tailor treatment pipelines for ALS patients may be necessary. The modelling...
Autores principales: | Morgan, Stephen, Duguez, Stephanie, Duddy, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313785/ https://www.ncbi.nlm.nih.gov/pubmed/30551677 http://dx.doi.org/10.3390/jpm8040044 |
Ejemplares similares
-
Genome-Wide Gene-Set Analysis Approaches in Amyotrophic Lateral Sclerosis
por: Vasilopoulou, Christina, et al.
Publicado: (2022) -
Extracellular Vesicles in Amyotrophic Lateral Sclerosis
por: McCluskey, Gavin, et al.
Publicado: (2022) -
What Can Machine Learning Approaches in Genomics Tell Us about the Molecular Basis of Amyotrophic Lateral Sclerosis?
por: Vasilopoulou, Christina, et al.
Publicado: (2020) -
The Cellular and Molecular Signature of ALS in Muscle
por: Anakor, Ekene, et al.
Publicado: (2022) -
Current knowledge and recent insights into the genetic basis of amyotrophic lateral sclerosis
por: Volk, Alexander E., et al.
Publicado: (2018)